Young Breast Cancer Cohort Study

Prospective Cohort Study for Development of Personalized Treatment Strategy Based on Biologic Tumor Behavior and Clinical Characteristics in Young Breast Cancer (YBC) Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03131089

Acronym

YBC

Enrollment

2000

Registered

2017-04-27

Start date

2013-04-11

Completion date

2023-04-10

Last updated

2017-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

This study is prospective cohort study to investigate and identify comprehensively the clinicopathological features and long-term outcome of young breast cancer (YBC). We have enrolled Breast cancer patients under 40 year-old and collected their baseline characteristics including tumor character, familiar history and other background information. Moreover, we have collected breast cancer tissue/blood sample for analyzing genetic characteristics, if patient agree to genetic analysis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

No minimum to 40 Years

Healthy volunteers

Inclusion criteria

1. Diagnosis with breast cancer 2. Age under 40 year-old or diagnosis with breast cancer at pregnancy or within 1year after delivery 3. Obtained informed consent form

Exclusion criteria

1\) Cannot understand or disagree to informed consent form

Design outcomes

Primary

Measure	Time frame	Description
Progression free survival	From date of surgery until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months	Time to detect disease recurrence from surgery date

Countries

South Korea

Contacts

Primary ContactYeon Hee Park, MD

yhparkhmo@skku.edu82-2-3410-1780

Outcome results